Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 138
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04974827 | A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer | ||
| NCT03351062 | Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer | ||
| NCT07237828 | Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR | ||
| NCT07163481 | A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors | ||
| NCT06486545 | Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer | ||
| NCT06047184 | Phase I Study of BEBT-209 in Women With Advanced Breast Cancer | ||
| NCT02918747 | PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage | ||
| NCT02527057 | Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer | ||
| NCT05342792 | Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma | ||
| NCT04193319 | Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects | ||
| NCT05882630 | Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer | ||
| NCT01285219 | A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy | ||
| NCT05367739 | Real World Study on the Efficacy and Safety of Anti-HER2 Therapy | ||
| NCT05113017 | The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE) | ||
| NCT03146455 | Thromboelastography Normal Reference Values in China Hunan Province | ||
| NCT05955391 | TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC) | ||
| NCT06321939 | Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma | ||
| NCT06031376 | Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC | ||
| NCT06836869 | Modified Tumor-free Techniques Operation to Cervical Cancer | ||
| NCT05535413 | UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases | ||
| NCT05206656 | Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer | ||
| NCT06190652 | Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC. | ||
| NCT05598528 | Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) | ||
| NCT01470495 | Combined Treatment of RFA and Sorafenib on Recurrent HCC | ||
| NCT05268172 | IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites | ||
| NCT06591078 | Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer | ||
| NCT06561308 | Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer | ||
| NCT05869097 | Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer | ||
| NCT06350838 | Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC) | ||
| NCT03637634 | The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study | ||
| NCT05211232 | Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma | ||
| NCT06748495 | Real-world First-line Serplulimab-based Immunochemotherapy for Extensive-stage Small Cell Lung Cancer | ||
| NCT07083687 | Lorlatinib in ROS1+ NSCLC With Brain Metastasis | ||
| NCT06328439 | A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors | ||
| NCT02448979 | Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach | ||
| NCT04733820 | Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery | ||
| NCT04922450 | Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT06492460 | 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma | ||
| NCT05427617 | Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer | ||
| NCT02355249 | Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer | ||
| NCT04459078 | Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma | ||
| NCT02958111 | Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | ||
| NCT06462105 | Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer | ||
| NCT05356351 | An Open-label, Single-arm, Multicenter Phase II Clinical Study： Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer | ||
| NCT04136886 | Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma | ||
| NCT06712888 | Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | ||
| NCT02717923 | A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer | ||
| NCT07314216 | Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma | ||
| NCT03895788 | A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer | ||
| NCT05273944 | Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients |
